92 related articles for article (PubMed ID: 8402568)
21. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue.
Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A
J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid receptor changes its cellular location with breast cancer development.
Conde I; Paniagua R; Fraile B; Lucio J; Arenas MI
Histol Histopathol; 2008 Jan; 23(1):77-85. PubMed ID: 17952860
[TBL] [Abstract][Full Text] [Related]
23. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
24. Human sodium iodide symporter (hNIS) in fibroadenoma breast--a immunohistochemical study.
Rai R; Shrivastava A; Tandon A; Godbole MM; Kumar S; Das V; Dwivedi V; Pal L
Indian J Exp Biol; 2011 Feb; 49(2):113-7. PubMed ID: 21428212
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
Reis-Filho JS; Cancela Paredes J; Milanezi F; Schmitt FC
Cancer; 2002 Apr; 94(7):2114-5; author reply 2115-6. PubMed ID: 11932917
[No Abstract] [Full Text] [Related]
26. Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: comparison of its distribution in normal, benign and malignant prostates.
Doctor VM; Sheth AR; Simha MM; Arbatti NJ; Aaveri JP; Sheth NA
Br J Cancer; 1986 Apr; 53(4):547-54. PubMed ID: 2423106
[TBL] [Abstract][Full Text] [Related]
27. Alveolar variant of invasive lobular carcinoma in a fibroadenoma.
Butler R; Pinsky R; Jorns JM
Breast J; 2012; 18(6):613-4. PubMed ID: 23009384
[No Abstract] [Full Text] [Related]
28. N-myc protein expression in human breast carcinoma: prognostic implications.
Mizukami Y; Nonomura A; Takizawa T; Noguchi M; Michigishi T; Nakamura S; Ishizaki T
Anticancer Res; 1995; 15(6B):2899-905. PubMed ID: 8669886
[TBL] [Abstract][Full Text] [Related]
29. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
[TBL] [Abstract][Full Text] [Related]
30. A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast.
Tibiletti MG; Sessa F; Bernasconi B; Cerutti R; Broggi B; Furlan D; Acquati F; Bianchi M; Russo A; Capella C; Taramelli R
Clin Cancer Res; 2000 Apr; 6(4):1422-31. PubMed ID: 10778973
[TBL] [Abstract][Full Text] [Related]
31. Carcinoma arising within fibroadenoma--a case report.
Vaideeswar P; Madiwale C; Sivaraman A
Indian J Pathol Microbiol; 2000 Jan; 43(1):87-9. PubMed ID: 12583428
[TBL] [Abstract][Full Text] [Related]
32. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Myers RB; Srivastava S; Oelschlager DK; Grizzle WE
J Natl Cancer Inst; 1994 Aug; 86(15):1140-5. PubMed ID: 7913137
[TBL] [Abstract][Full Text] [Related]
33. [Distribution of actin isoforms in normal, dysplastic, and tumorous human breast cells].
Dugina VB; Chipysheva TA; Ermilova VD; Gabbiani D; Chaponnier C; Vasil'ev IuM
Arkh Patol; 2008; 70(2):28-31. PubMed ID: 18540438
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-kit proto-oncogene product in breast tissue.
Yared MA; Middleton LP; Meric F; Cristofanilli M; Sahin AA
Breast J; 2004; 10(4):323-7. PubMed ID: 15239791
[TBL] [Abstract][Full Text] [Related]
35. Expression of scatter factor and c-met receptor in benign and malignant breast tissue.
Jin L; Fuchs A; Schnitt SJ; Yao Y; Joseph A; Lamszus K; Park M; Goldberg ID; Rosen EM
Cancer; 1997 Feb; 79(4):749-60. PubMed ID: 9024713
[TBL] [Abstract][Full Text] [Related]
36. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma.
Petraglia F; Florio P; Luisi S; Gallo R; Gadducci A; Viganò P; Di Blasio AM; Genazzani AR; Vale W
J Clin Endocrinol Metab; 1998 Apr; 83(4):1194-200. PubMed ID: 9543140
[TBL] [Abstract][Full Text] [Related]
37. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
38. Palisaded and verocay bodies in fibroadenoma of the breast.
Guray M; Canda T; Sevinç IA
Breast J; 2009; 15(6):663-4. PubMed ID: 19995381
[No Abstract] [Full Text] [Related]
39. Interaction with the GDF8/11 pathway reveals treatment options for adenocarcinoma of the breast.
Wallner C; Drysch M; Becerikli M; Jaurich H; Wagner JM; Dittfeld S; Nagler J; Harati K; Dadras M; Philippou S; Lehnhardt M; Behr B
Breast; 2018 Feb; 37():134-141. PubMed ID: 29156385
[TBL] [Abstract][Full Text] [Related]
40. P53 expression in patients with malignant and benign breast diseases.
Kalogeraki A; Panayiotides J; Tamiolakis D; Tzardi M; Chaniotis V; Chalkiadakis G; Melissas J; Stiftsis D; Kanavaros P; Delides GS
Anticancer Res; 2000; 20(3A):1801-5. PubMed ID: 10928110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
